Author:
Reddy Jagadeshwar G.,Loftus Edward V.
Reference126 articles.
1. Remicade (infliximab) for IV injection [prescribing information]. Malvern, PA: Centocor; 2006.
2. Maintenance of remission over 1 year in patients with active Crohn's disease treated with adalimumab: results of a blinded, placebo-controlled study;Sandborn;Am J Gastroenterol,2005
3. Remission and clinical response induced and maintained in patients with active Crohn's disease treated for 1-year open-label with adalimumab;Sandborn;Am J Gastroenterol,2005
4. A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease;Schreiber;Gastroenterology,2005
5. Certolizumab pegol, a humanised anti-TNF pegylated FAb' fragment, is safe and effective in the maintenance of response and remission following induction in active Crohn's disease: a phase III study (Precise);Schreiber;Gut,2005
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献